nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—CYP2A6—Amobarbital—epilepsy syndrome	0.0465	0.0728	CbGbCtD
Montelukast—CYP2A6—Propofol—epilepsy syndrome	0.0347	0.0543	CbGbCtD
Montelukast—CYP2A6—Phenobarbital—epilepsy syndrome	0.0332	0.0519	CbGbCtD
Montelukast—CYP2C8—Trimethadione—epilepsy syndrome	0.0303	0.0474	CbGbCtD
Montelukast—CYP2C8—Fosphenytoin—epilepsy syndrome	0.0285	0.0445	CbGbCtD
Montelukast—PTGS1—Diazepam—epilepsy syndrome	0.0269	0.042	CbGbCtD
Montelukast—CYP2A6—Valproic Acid—epilepsy syndrome	0.0248	0.0388	CbGbCtD
Montelukast—PTGS1—Valproic Acid—epilepsy syndrome	0.0212	0.0331	CbGbCtD
Montelukast—CYP2C9—Trimethadione—epilepsy syndrome	0.0211	0.033	CbGbCtD
Montelukast—CYP2C8—Carbamazepine—epilepsy syndrome	0.0204	0.032	CbGbCtD
Montelukast—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0199	0.0311	CbGbCtD
Montelukast—CYP2C8—Primidone—epilepsy syndrome	0.0191	0.0299	CbGbCtD
Montelukast—CYP2C8—Phenytoin—epilepsy syndrome	0.0183	0.0287	CbGbCtD
Montelukast—CYP2C8—Propofol—epilepsy syndrome	0.0171	0.0268	CbGbCtD
Montelukast—CYP2C8—Phenobarbital—epilepsy syndrome	0.0163	0.0256	CbGbCtD
Montelukast—CYP2C8—Diazepam—epilepsy syndrome	0.0155	0.0242	CbGbCtD
Montelukast—CYP2C9—Carbamazepine—epilepsy syndrome	0.0143	0.0223	CbGbCtD
Montelukast—CYP2C9—Primidone—epilepsy syndrome	0.0133	0.0208	CbGbCtD
Montelukast—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0132	0.0207	CbGbCtD
Montelukast—CYP2C9—Phenytoin—epilepsy syndrome	0.0128	0.02	CbGbCtD
Montelukast—CYP3A4—Felbamate—epilepsy syndrome	0.0123	0.0192	CbGbCtD
Montelukast—CYP3A4—Trimethadione—epilepsy syndrome	0.0123	0.0192	CbGbCtD
Montelukast—CYP2C8—Valproic Acid—epilepsy syndrome	0.0122	0.0191	CbGbCtD
Montelukast—CYP2C9—Propofol—epilepsy syndrome	0.0119	0.0187	CbGbCtD
Montelukast—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0115	0.0181	CbGbCtD
Montelukast—CYP2C9—Phenobarbital—epilepsy syndrome	0.0114	0.0178	CbGbCtD
Montelukast—CYP2C9—Diazepam—epilepsy syndrome	0.0108	0.0169	CbGbCtD
Montelukast—CYP3A4—Clonazepam—epilepsy syndrome	0.0104	0.0163	CbGbCtD
Montelukast—CYP3A4—Clobazam—epilepsy syndrome	0.01	0.0157	CbGbCtD
Montelukast—CYP2C9—Valproic Acid—epilepsy syndrome	0.00852	0.0133	CbGbCtD
Montelukast—CYP3A4—Rufinamide—epilepsy syndrome	0.00851	0.0133	CbGbCtD
Montelukast—CYP3A4—Carbamazepine—epilepsy syndrome	0.00829	0.013	CbGbCtD
Montelukast—CYP3A4—Primidone—epilepsy syndrome	0.00774	0.0121	CbGbCtD
Montelukast—CYP3A4—Phenytoin—epilepsy syndrome	0.00744	0.0116	CbGbCtD
Montelukast—CYP3A4—Propofol—epilepsy syndrome	0.00694	0.0109	CbGbCtD
Montelukast—CYP3A4—Acetazolamide—epilepsy syndrome	0.00663	0.0104	CbGbCtD
Montelukast—CYP3A4—Phenobarbital—epilepsy syndrome	0.00663	0.0104	CbGbCtD
Montelukast—CYP3A4—Midazolam—epilepsy syndrome	0.00654	0.0102	CbGbCtD
Montelukast—CYP3A4—Diazepam—epilepsy syndrome	0.00629	0.00983	CbGbCtD
Montelukast—CYP3A4—Zonisamide—epilepsy syndrome	0.00613	0.0096	CbGbCtD
Montelukast—CYP3A4—Valproic Acid—epilepsy syndrome	0.00495	0.00775	CbGbCtD
Montelukast—CYP3A4—Topiramate—epilepsy syndrome	0.00447	0.00699	CbGbCtD
Montelukast—SLCO2B1—ganglion—epilepsy syndrome	0.00113	0.111	CbGeAlD
Montelukast—PTGS1—ganglion—epilepsy syndrome	0.00059	0.058	CbGeAlD
Montelukast—CYSLTR1—head—epilepsy syndrome	0.000584	0.0574	CbGeAlD
Montelukast—CYSLTR1—nervous system—epilepsy syndrome	0.000553	0.0544	CbGeAlD
Montelukast—CYSLTR1—central nervous system—epilepsy syndrome	0.000533	0.0524	CbGeAlD
Montelukast—SLCO2B1—forebrain—epilepsy syndrome	0.000475	0.0467	CbGeAlD
Montelukast—SLCO2B1—telencephalon—epilepsy syndrome	0.000437	0.0429	CbGeAlD
Montelukast—CYSLTR1—brain—epilepsy syndrome	0.000423	0.0416	CbGeAlD
Montelukast—ALOX5—head—epilepsy syndrome	0.000353	0.0347	CbGeAlD
Montelukast—SLCO2B1—medulla oblongata—epilepsy syndrome	0.000343	0.0337	CbGeAlD
Montelukast—ALOX5—nervous system—epilepsy syndrome	0.000335	0.0329	CbGeAlD
Montelukast—ALOX5—central nervous system—epilepsy syndrome	0.000323	0.0317	CbGeAlD
Montelukast—ALOX5—cerebellum—epilepsy syndrome	0.000315	0.031	CbGeAlD
Montelukast—SLCO2B1—spinal cord—epilepsy syndrome	0.000306	0.0301	CbGeAlD
Montelukast—CYP2A6—cerebellum—epilepsy syndrome	0.000278	0.0273	CbGeAlD
Montelukast—SLCO2B1—head—epilepsy syndrome	0.000272	0.0267	CbGeAlD
Montelukast—SLCO2B1—nervous system—epilepsy syndrome	0.000258	0.0254	CbGeAlD
Montelukast—ALOX5—brain—epilepsy syndrome	0.000256	0.0252	CbGeAlD
Montelukast—SLCO2B1—central nervous system—epilepsy syndrome	0.000248	0.0244	CbGeAlD
Montelukast—PTGS1—forebrain—epilepsy syndrome	0.000248	0.0244	CbGeAlD
Montelukast—SLCO2B1—cerebellum—epilepsy syndrome	0.000243	0.0239	CbGeAlD
Montelukast—PTGS1—telencephalon—epilepsy syndrome	0.000228	0.0224	CbGeAlD
Montelukast—CYP2A6—brain—epilepsy syndrome	0.000226	0.0222	CbGeAlD
Montelukast—SLCO2B1—brain—epilepsy syndrome	0.000197	0.0194	CbGeAlD
Montelukast—PTGS1—spinal cord—epilepsy syndrome	0.00016	0.0157	CbGeAlD
Montelukast—PTGS1—head—epilepsy syndrome	0.000142	0.0139	CbGeAlD
Montelukast—PTGS1—nervous system—epilepsy syndrome	0.000134	0.0132	CbGeAlD
Montelukast—PTGS1—central nervous system—epilepsy syndrome	0.000129	0.0127	CbGeAlD
Montelukast—CYP2C8—brain—epilepsy syndrome	0.000127	0.0125	CbGeAlD
Montelukast—CYP3A4—nervous system—epilepsy syndrome	0.000112	0.011	CbGeAlD
Montelukast—CYP3A4—central nervous system—epilepsy syndrome	0.000108	0.0106	CbGeAlD
Montelukast—PTGS1—brain—epilepsy syndrome	0.000103	0.0101	CbGeAlD
Montelukast—Body temperature increased—Carbamazepine—epilepsy syndrome	8.15e-05	0.000319	CcSEcCtD
Montelukast—Diarrhoea—Diazepam—epilepsy syndrome	8.15e-05	0.000319	CcSEcCtD
Montelukast—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	8.15e-05	0.000319	CcSEcCtD
Montelukast—Sinusitis—Topiramate—epilepsy syndrome	8.12e-05	0.000318	CcSEcCtD
Montelukast—Rash—Levetiracetam—epilepsy syndrome	8.11e-05	0.000317	CcSEcCtD
Montelukast—Dermatitis—Levetiracetam—epilepsy syndrome	8.1e-05	0.000317	CcSEcCtD
Montelukast—Asthenia—Zonisamide—epilepsy syndrome	8.09e-05	0.000317	CcSEcCtD
Montelukast—Mental disorder—Gabapentin—epilepsy syndrome	8.09e-05	0.000317	CcSEcCtD
Montelukast—Agitation—Pregabalin—epilepsy syndrome	8.06e-05	0.000315	CcSEcCtD
Montelukast—Headache—Levetiracetam—epilepsy syndrome	8.05e-05	0.000315	CcSEcCtD
Montelukast—Angioedema—Pregabalin—epilepsy syndrome	8.01e-05	0.000314	CcSEcCtD
Montelukast—Hypersensitivity—Clonazepam—epilepsy syndrome	8.01e-05	0.000314	CcSEcCtD
Montelukast—Dizziness—Vigabatrin—epilepsy syndrome	8e-05	0.000313	CcSEcCtD
Montelukast—Pruritus—Zonisamide—epilepsy syndrome	7.98e-05	0.000312	CcSEcCtD
Montelukast—Hypersensitivity—Phenytoin—epilepsy syndrome	7.96e-05	0.000311	CcSEcCtD
Montelukast—Oedema—Valproic Acid—epilepsy syndrome	7.92e-05	0.00031	CcSEcCtD
Montelukast—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.92e-05	0.00031	CcSEcCtD
Montelukast—Urticaria—Lamotrigine—epilepsy syndrome	7.91e-05	0.00031	CcSEcCtD
Montelukast—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.91e-05	0.00031	CcSEcCtD
Montelukast—Nausea—Propofol—epilepsy syndrome	7.9e-05	0.000309	CcSEcCtD
Montelukast—Vomiting—Fosphenytoin—epilepsy syndrome	7.89e-05	0.000309	CcSEcCtD
Montelukast—Diarrhoea—Felbamate—epilepsy syndrome	7.88e-05	0.000309	CcSEcCtD
Montelukast—Body temperature increased—Lamotrigine—epilepsy syndrome	7.88e-05	0.000308	CcSEcCtD
Montelukast—Abdominal pain—Lamotrigine—epilepsy syndrome	7.88e-05	0.000308	CcSEcCtD
Montelukast—Dizziness—Diazepam—epilepsy syndrome	7.87e-05	0.000308	CcSEcCtD
Montelukast—Infection—Valproic Acid—epilepsy syndrome	7.86e-05	0.000308	CcSEcCtD
Montelukast—Rash—Fosphenytoin—epilepsy syndrome	7.82e-05	0.000306	CcSEcCtD
Montelukast—Dermatitis—Fosphenytoin—epilepsy syndrome	7.82e-05	0.000306	CcSEcCtD
Montelukast—Asthenia—Clonazepam—epilepsy syndrome	7.8e-05	0.000305	CcSEcCtD
Montelukast—Rhinitis—Topiramate—epilepsy syndrome	7.79e-05	0.000305	CcSEcCtD
Montelukast—Headache—Fosphenytoin—epilepsy syndrome	7.77e-05	0.000304	CcSEcCtD
Montelukast—Hepatitis—Topiramate—epilepsy syndrome	7.77e-05	0.000304	CcSEcCtD
Montelukast—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.76e-05	0.000304	CcSEcCtD
Montelukast—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.75e-05	0.000303	CcSEcCtD
Montelukast—Palpitations—Pregabalin—epilepsy syndrome	7.75e-05	0.000303	CcSEcCtD
Montelukast—Asthenia—Phenytoin—epilepsy syndrome	7.75e-05	0.000303	CcSEcCtD
Montelukast—Nausea—Midazolam—epilepsy syndrome	7.73e-05	0.000303	CcSEcCtD
Montelukast—Hallucination—Topiramate—epilepsy syndrome	7.73e-05	0.000303	CcSEcCtD
Montelukast—Hypoaesthesia—Topiramate—epilepsy syndrome	7.73e-05	0.000303	CcSEcCtD
Montelukast—Muscle spasms—Gabapentin—epilepsy syndrome	7.73e-05	0.000303	CcSEcCtD
Montelukast—Diarrhoea—Zonisamide—epilepsy syndrome	7.72e-05	0.000302	CcSEcCtD
Montelukast—Pharyngitis—Topiramate—epilepsy syndrome	7.71e-05	0.000302	CcSEcCtD
Montelukast—Asthenia—Oxcarbazepine—epilepsy syndrome	7.71e-05	0.000302	CcSEcCtD
Montelukast—Pruritus—Clonazepam—epilepsy syndrome	7.69e-05	0.000301	CcSEcCtD
Montelukast—Vomiting—Vigabatrin—epilepsy syndrome	7.69e-05	0.000301	CcSEcCtD
Montelukast—Skin disorder—Valproic Acid—epilepsy syndrome	7.69e-05	0.000301	CcSEcCtD
Montelukast—Urinary tract disorder—Topiramate—epilepsy syndrome	7.67e-05	0.0003	CcSEcCtD
Montelukast—Cough—Pregabalin—epilepsy syndrome	7.65e-05	0.0003	CcSEcCtD
Montelukast—Pruritus—Phenytoin—epilepsy syndrome	7.64e-05	0.000299	CcSEcCtD
Montelukast—Connective tissue disorder—Topiramate—epilepsy syndrome	7.64e-05	0.000299	CcSEcCtD
Montelukast—Nausea—Levetiracetam—epilepsy syndrome	7.64e-05	0.000299	CcSEcCtD
Montelukast—Rash—Vigabatrin—epilepsy syndrome	7.63e-05	0.000298	CcSEcCtD
Montelukast—Dizziness—Felbamate—epilepsy syndrome	7.62e-05	0.000298	CcSEcCtD
Montelukast—Dermatitis—Vigabatrin—epilepsy syndrome	7.62e-05	0.000298	CcSEcCtD
Montelukast—Urethral disorder—Topiramate—epilepsy syndrome	7.62e-05	0.000298	CcSEcCtD
Montelukast—Pruritus—Oxcarbazepine—epilepsy syndrome	7.6e-05	0.000297	CcSEcCtD
Montelukast—Convulsion—Pregabalin—epilepsy syndrome	7.6e-05	0.000297	CcSEcCtD
Montelukast—Hypersensitivity—Carbamazepine—epilepsy syndrome	7.59e-05	0.000297	CcSEcCtD
Montelukast—Headache—Vigabatrin—epilepsy syndrome	7.58e-05	0.000297	CcSEcCtD
Montelukast—Vomiting—Diazepam—epilepsy syndrome	7.57e-05	0.000296	CcSEcCtD
Montelukast—Tremor—Gabapentin—epilepsy syndrome	7.53e-05	0.000295	CcSEcCtD
Montelukast—Rash—Diazepam—epilepsy syndrome	7.51e-05	0.000294	CcSEcCtD
Montelukast—Dermatitis—Diazepam—epilepsy syndrome	7.5e-05	0.000294	CcSEcCtD
Montelukast—Arthralgia—Pregabalin—epilepsy syndrome	7.47e-05	0.000292	CcSEcCtD
Montelukast—Myalgia—Pregabalin—epilepsy syndrome	7.47e-05	0.000292	CcSEcCtD
Montelukast—Dizziness—Zonisamide—epilepsy syndrome	7.46e-05	0.000292	CcSEcCtD
Montelukast—Headache—Diazepam—epilepsy syndrome	7.46e-05	0.000292	CcSEcCtD
Montelukast—Anxiety—Pregabalin—epilepsy syndrome	7.44e-05	0.000291	CcSEcCtD
Montelukast—Diarrhoea—Clonazepam—epilepsy syndrome	7.44e-05	0.000291	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	7.41e-05	0.00029	CcSEcCtD
Montelukast—Asthenia—Carbamazepine—epilepsy syndrome	7.4e-05	0.000289	CcSEcCtD
Montelukast—Agitation—Gabapentin—epilepsy syndrome	7.39e-05	0.000289	CcSEcCtD
Montelukast—Diarrhoea—Phenytoin—epilepsy syndrome	7.39e-05	0.000289	CcSEcCtD
Montelukast—Nausea—Fosphenytoin—epilepsy syndrome	7.37e-05	0.000288	CcSEcCtD
Montelukast—Diarrhoea—Oxcarbazepine—epilepsy syndrome	7.35e-05	0.000288	CcSEcCtD
Montelukast—Erythema multiforme—Topiramate—epilepsy syndrome	7.35e-05	0.000288	CcSEcCtD
Montelukast—Angioedema—Gabapentin—epilepsy syndrome	7.35e-05	0.000288	CcSEcCtD
Montelukast—Hypersensitivity—Lamotrigine—epilepsy syndrome	7.34e-05	0.000287	CcSEcCtD
Montelukast—Vomiting—Felbamate—epilepsy syndrome	7.33e-05	0.000287	CcSEcCtD
Montelukast—Pruritus—Carbamazepine—epilepsy syndrome	7.29e-05	0.000285	CcSEcCtD
Montelukast—Rash—Felbamate—epilepsy syndrome	7.27e-05	0.000284	CcSEcCtD
Montelukast—Dermatitis—Felbamate—epilepsy syndrome	7.26e-05	0.000284	CcSEcCtD
Montelukast—Headache—Felbamate—epilepsy syndrome	7.22e-05	0.000283	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	7.21e-05	0.000282	CcSEcCtD
Montelukast—Cardiac disorder—Topiramate—epilepsy syndrome	7.21e-05	0.000282	CcSEcCtD
Montelukast—Dizziness—Clonazepam—epilepsy syndrome	7.19e-05	0.000281	CcSEcCtD
Montelukast—Nausea—Vigabatrin—epilepsy syndrome	7.18e-05	0.000281	CcSEcCtD
Montelukast—Vomiting—Zonisamide—epilepsy syndrome	7.17e-05	0.000281	CcSEcCtD
Montelukast—Insomnia—Valproic Acid—epilepsy syndrome	7.16e-05	0.00028	CcSEcCtD
Montelukast—Anaphylactic shock—Pregabalin—epilepsy syndrome	7.16e-05	0.00028	CcSEcCtD
Montelukast—Oedema—Pregabalin—epilepsy syndrome	7.16e-05	0.00028	CcSEcCtD
Montelukast—Asthenia—Lamotrigine—epilepsy syndrome	7.15e-05	0.00028	CcSEcCtD
Montelukast—Dizziness—Phenytoin—epilepsy syndrome	7.14e-05	0.00028	CcSEcCtD
Montelukast—Rash—Zonisamide—epilepsy syndrome	7.11e-05	0.000278	CcSEcCtD
Montelukast—Infection—Pregabalin—epilepsy syndrome	7.11e-05	0.000278	CcSEcCtD
Montelukast—Paraesthesia—Valproic Acid—epilepsy syndrome	7.11e-05	0.000278	CcSEcCtD
Montelukast—Palpitations—Gabapentin—epilepsy syndrome	7.11e-05	0.000278	CcSEcCtD
Montelukast—Dermatitis—Zonisamide—epilepsy syndrome	7.11e-05	0.000278	CcSEcCtD
Montelukast—Dizziness—Oxcarbazepine—epilepsy syndrome	7.1e-05	0.000278	CcSEcCtD
Montelukast—Nausea—Diazepam—epilepsy syndrome	7.07e-05	0.000277	CcSEcCtD
Montelukast—Headache—Zonisamide—epilepsy syndrome	7.07e-05	0.000277	CcSEcCtD
Montelukast—Diarrhoea—Carbamazepine—epilepsy syndrome	7.05e-05	0.000276	CcSEcCtD
Montelukast—Pruritus—Lamotrigine—epilepsy syndrome	7.05e-05	0.000276	CcSEcCtD
Montelukast—Somnolence—Valproic Acid—epilepsy syndrome	7.04e-05	0.000275	CcSEcCtD
Montelukast—Immune system disorder—Topiramate—epilepsy syndrome	7.02e-05	0.000275	CcSEcCtD
Montelukast—Nervous system disorder—Pregabalin—epilepsy syndrome	7.02e-05	0.000275	CcSEcCtD
Montelukast—Cough—Gabapentin—epilepsy syndrome	7.02e-05	0.000275	CcSEcCtD
Montelukast—Thrombocytopenia—Pregabalin—epilepsy syndrome	7.01e-05	0.000274	CcSEcCtD
Montelukast—Mediastinal disorder—Topiramate—epilepsy syndrome	7e-05	0.000274	CcSEcCtD
Montelukast—Dyspepsia—Valproic Acid—epilepsy syndrome	6.97e-05	0.000273	CcSEcCtD
Montelukast—Convulsion—Gabapentin—epilepsy syndrome	6.97e-05	0.000273	CcSEcCtD
Montelukast—Skin disorder—Pregabalin—epilepsy syndrome	6.95e-05	0.000272	CcSEcCtD
Montelukast—Vomiting—Clonazepam—epilepsy syndrome	6.91e-05	0.000271	CcSEcCtD
Montelukast—Vomiting—Phenytoin—epilepsy syndrome	6.87e-05	0.000269	CcSEcCtD
Montelukast—Rash—Clonazepam—epilepsy syndrome	6.85e-05	0.000268	CcSEcCtD
Montelukast—Dermatitis—Clonazepam—epilepsy syndrome	6.85e-05	0.000268	CcSEcCtD
Montelukast—Arthralgia—Gabapentin—epilepsy syndrome	6.85e-05	0.000268	CcSEcCtD
Montelukast—Myalgia—Gabapentin—epilepsy syndrome	6.85e-05	0.000268	CcSEcCtD
Montelukast—Nausea—Felbamate—epilepsy syndrome	6.84e-05	0.000268	CcSEcCtD
Montelukast—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.83e-05	0.000268	CcSEcCtD
Montelukast—Vomiting—Oxcarbazepine—epilepsy syndrome	6.83e-05	0.000267	CcSEcCtD
Montelukast—Fatigue—Valproic Acid—epilepsy syndrome	6.82e-05	0.000267	CcSEcCtD
Montelukast—Anxiety—Gabapentin—epilepsy syndrome	6.82e-05	0.000267	CcSEcCtD
Montelukast—Dizziness—Carbamazepine—epilepsy syndrome	6.82e-05	0.000267	CcSEcCtD
Montelukast—Diarrhoea—Lamotrigine—epilepsy syndrome	6.82e-05	0.000267	CcSEcCtD
Montelukast—Headache—Clonazepam—epilepsy syndrome	6.81e-05	0.000267	CcSEcCtD
Montelukast—Rash—Phenytoin—epilepsy syndrome	6.81e-05	0.000267	CcSEcCtD
Montelukast—Mental disorder—Topiramate—epilepsy syndrome	6.81e-05	0.000267	CcSEcCtD
Montelukast—Dermatitis—Phenytoin—epilepsy syndrome	6.8e-05	0.000266	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.8e-05	0.000266	CcSEcCtD
Montelukast—Rash—Oxcarbazepine—epilepsy syndrome	6.77e-05	0.000265	CcSEcCtD
Montelukast—Pain—Valproic Acid—epilepsy syndrome	6.77e-05	0.000265	CcSEcCtD
Montelukast—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.77e-05	0.000265	CcSEcCtD
Montelukast—Headache—Phenytoin—epilepsy syndrome	6.76e-05	0.000265	CcSEcCtD
Montelukast—Headache—Oxcarbazepine—epilepsy syndrome	6.73e-05	0.000263	CcSEcCtD
Montelukast—Nausea—Zonisamide—epilepsy syndrome	6.7e-05	0.000262	CcSEcCtD
Montelukast—Dizziness—Lamotrigine—epilepsy syndrome	6.59e-05	0.000258	CcSEcCtD
Montelukast—Oedema—Gabapentin—epilepsy syndrome	6.56e-05	0.000257	CcSEcCtD
Montelukast—Anaphylactic shock—Gabapentin—epilepsy syndrome	6.56e-05	0.000257	CcSEcCtD
Montelukast—Vomiting—Carbamazepine—epilepsy syndrome	6.55e-05	0.000257	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	6.52e-05	0.000255	CcSEcCtD
Montelukast—Infection—Gabapentin—epilepsy syndrome	6.52e-05	0.000255	CcSEcCtD
Montelukast—Muscle spasms—Topiramate—epilepsy syndrome	6.5e-05	0.000255	CcSEcCtD
Montelukast—Rash—Carbamazepine—epilepsy syndrome	6.5e-05	0.000254	CcSEcCtD
Montelukast—Dermatitis—Carbamazepine—epilepsy syndrome	6.49e-05	0.000254	CcSEcCtD
Montelukast—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	6.47e-05	0.000253	CcSEcCtD
Montelukast—Insomnia—Pregabalin—epilepsy syndrome	6.47e-05	0.000253	CcSEcCtD
Montelukast—Nausea—Clonazepam—epilepsy syndrome	6.46e-05	0.000253	CcSEcCtD
Montelukast—Headache—Carbamazepine—epilepsy syndrome	6.46e-05	0.000253	CcSEcCtD
Montelukast—Nervous system disorder—Gabapentin—epilepsy syndrome	6.44e-05	0.000252	CcSEcCtD
Montelukast—Paraesthesia—Pregabalin—epilepsy syndrome	6.43e-05	0.000252	CcSEcCtD
Montelukast—Thrombocytopenia—Gabapentin—epilepsy syndrome	6.43e-05	0.000252	CcSEcCtD
Montelukast—Nausea—Phenytoin—epilepsy syndrome	6.41e-05	0.000251	CcSEcCtD
Montelukast—Nausea—Oxcarbazepine—epilepsy syndrome	6.38e-05	0.00025	CcSEcCtD
Montelukast—Skin disorder—Gabapentin—epilepsy syndrome	6.37e-05	0.00025	CcSEcCtD
Montelukast—Somnolence—Pregabalin—epilepsy syndrome	6.36e-05	0.000249	CcSEcCtD
Montelukast—Tremor—Topiramate—epilepsy syndrome	6.34e-05	0.000248	CcSEcCtD
Montelukast—Vomiting—Lamotrigine—epilepsy syndrome	6.33e-05	0.000248	CcSEcCtD
Montelukast—Urticaria—Valproic Acid—epilepsy syndrome	6.29e-05	0.000246	CcSEcCtD
Montelukast—Rash—Lamotrigine—epilepsy syndrome	6.28e-05	0.000246	CcSEcCtD
Montelukast—Dermatitis—Lamotrigine—epilepsy syndrome	6.28e-05	0.000246	CcSEcCtD
Montelukast—Abdominal pain—Valproic Acid—epilepsy syndrome	6.26e-05	0.000245	CcSEcCtD
Montelukast—Body temperature increased—Valproic Acid—epilepsy syndrome	6.26e-05	0.000245	CcSEcCtD
Montelukast—Headache—Lamotrigine—epilepsy syndrome	6.24e-05	0.000244	CcSEcCtD
Montelukast—Agitation—Topiramate—epilepsy syndrome	6.22e-05	0.000243	CcSEcCtD
Montelukast—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	6.18e-05	0.000242	CcSEcCtD
Montelukast—Fatigue—Pregabalin—epilepsy syndrome	6.17e-05	0.000242	CcSEcCtD
Montelukast—Nausea—Carbamazepine—epilepsy syndrome	6.12e-05	0.00024	CcSEcCtD
Montelukast—Pain—Pregabalin—epilepsy syndrome	6.12e-05	0.00024	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.98e-05	0.000234	CcSEcCtD
Montelukast—Palpitations—Topiramate—epilepsy syndrome	5.98e-05	0.000234	CcSEcCtD
Montelukast—Insomnia—Gabapentin—epilepsy syndrome	5.94e-05	0.000232	CcSEcCtD
Montelukast—Nausea—Lamotrigine—epilepsy syndrome	5.92e-05	0.000232	CcSEcCtD
Montelukast—Cough—Topiramate—epilepsy syndrome	5.9e-05	0.000231	CcSEcCtD
Montelukast—Paraesthesia—Gabapentin—epilepsy syndrome	5.89e-05	0.000231	CcSEcCtD
Montelukast—Convulsion—Topiramate—epilepsy syndrome	5.86e-05	0.000229	CcSEcCtD
Montelukast—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.85e-05	0.000229	CcSEcCtD
Montelukast—Somnolence—Gabapentin—epilepsy syndrome	5.83e-05	0.000228	CcSEcCtD
Montelukast—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.83e-05	0.000228	CcSEcCtD
Montelukast—Dyspepsia—Gabapentin—epilepsy syndrome	5.78e-05	0.000226	CcSEcCtD
Montelukast—Myalgia—Topiramate—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Montelukast—Arthralgia—Topiramate—epilepsy syndrome	5.76e-05	0.000225	CcSEcCtD
Montelukast—Anxiety—Topiramate—epilepsy syndrome	5.74e-05	0.000225	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.72e-05	0.000224	CcSEcCtD
Montelukast—Urticaria—Pregabalin—epilepsy syndrome	5.69e-05	0.000223	CcSEcCtD
Montelukast—Asthenia—Valproic Acid—epilepsy syndrome	5.68e-05	0.000222	CcSEcCtD
Montelukast—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.67e-05	0.000222	CcSEcCtD
Montelukast—Fatigue—Gabapentin—epilepsy syndrome	5.66e-05	0.000221	CcSEcCtD
Montelukast—Body temperature increased—Pregabalin—epilepsy syndrome	5.66e-05	0.000221	CcSEcCtD
Montelukast—Abdominal pain—Pregabalin—epilepsy syndrome	5.66e-05	0.000221	CcSEcCtD
Montelukast—Pain—Gabapentin—epilepsy syndrome	5.61e-05	0.00022	CcSEcCtD
Montelukast—Pruritus—Valproic Acid—epilepsy syndrome	5.6e-05	0.000219	CcSEcCtD
Montelukast—Oedema—Topiramate—epilepsy syndrome	5.52e-05	0.000216	CcSEcCtD
Montelukast—Infection—Topiramate—epilepsy syndrome	5.48e-05	0.000215	CcSEcCtD
Montelukast—Diarrhoea—Valproic Acid—epilepsy syndrome	5.42e-05	0.000212	CcSEcCtD
Montelukast—Nervous system disorder—Topiramate—epilepsy syndrome	5.41e-05	0.000212	CcSEcCtD
Montelukast—Thrombocytopenia—Topiramate—epilepsy syndrome	5.41e-05	0.000212	CcSEcCtD
Montelukast—Gastrointestinal pain—Gabapentin—epilepsy syndrome	5.37e-05	0.00021	CcSEcCtD
Montelukast—Skin disorder—Topiramate—epilepsy syndrome	5.36e-05	0.00021	CcSEcCtD
Montelukast—Hypersensitivity—Pregabalin—epilepsy syndrome	5.27e-05	0.000206	CcSEcCtD
Montelukast—Dizziness—Valproic Acid—epilepsy syndrome	5.23e-05	0.000205	CcSEcCtD
Montelukast—Urticaria—Gabapentin—epilepsy syndrome	5.21e-05	0.000204	CcSEcCtD
Montelukast—Body temperature increased—Gabapentin—epilepsy syndrome	5.19e-05	0.000203	CcSEcCtD
Montelukast—Abdominal pain—Gabapentin—epilepsy syndrome	5.19e-05	0.000203	CcSEcCtD
Montelukast—Asthenia—Pregabalin—epilepsy syndrome	5.13e-05	0.000201	CcSEcCtD
Montelukast—Pruritus—Pregabalin—epilepsy syndrome	5.06e-05	0.000198	CcSEcCtD
Montelukast—Vomiting—Valproic Acid—epilepsy syndrome	5.03e-05	0.000197	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	5.03e-05	0.000197	CcSEcCtD
Montelukast—Insomnia—Topiramate—epilepsy syndrome	4.99e-05	0.000195	CcSEcCtD
Montelukast—Rash—Valproic Acid—epilepsy syndrome	4.99e-05	0.000195	CcSEcCtD
Montelukast—Dermatitis—Valproic Acid—epilepsy syndrome	4.99e-05	0.000195	CcSEcCtD
Montelukast—Headache—Valproic Acid—epilepsy syndrome	4.96e-05	0.000194	CcSEcCtD
Montelukast—Paraesthesia—Topiramate—epilepsy syndrome	4.96e-05	0.000194	CcSEcCtD
Montelukast—Somnolence—Topiramate—epilepsy syndrome	4.91e-05	0.000192	CcSEcCtD
Montelukast—Diarrhoea—Pregabalin—epilepsy syndrome	4.9e-05	0.000192	CcSEcCtD
Montelukast—Dyspepsia—Topiramate—epilepsy syndrome	4.86e-05	0.00019	CcSEcCtD
Montelukast—Hypersensitivity—Gabapentin—epilepsy syndrome	4.83e-05	0.000189	CcSEcCtD
Montelukast—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.77e-05	0.000187	CcSEcCtD
Montelukast—Fatigue—Topiramate—epilepsy syndrome	4.76e-05	0.000186	CcSEcCtD
Montelukast—Dizziness—Pregabalin—epilepsy syndrome	4.73e-05	0.000185	CcSEcCtD
Montelukast—Pain—Topiramate—epilepsy syndrome	4.72e-05	0.000185	CcSEcCtD
Montelukast—Asthenia—Gabapentin—epilepsy syndrome	4.71e-05	0.000184	CcSEcCtD
Montelukast—Nausea—Valproic Acid—epilepsy syndrome	4.7e-05	0.000184	CcSEcCtD
Montelukast—Pruritus—Gabapentin—epilepsy syndrome	4.64e-05	0.000182	CcSEcCtD
Montelukast—Vomiting—Pregabalin—epilepsy syndrome	4.55e-05	0.000178	CcSEcCtD
Montelukast—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.51e-05	0.000177	CcSEcCtD
Montelukast—Rash—Pregabalin—epilepsy syndrome	4.51e-05	0.000177	CcSEcCtD
Montelukast—Dermatitis—Pregabalin—epilepsy syndrome	4.51e-05	0.000176	CcSEcCtD
Montelukast—Diarrhoea—Gabapentin—epilepsy syndrome	4.49e-05	0.000176	CcSEcCtD
Montelukast—Headache—Pregabalin—epilepsy syndrome	4.48e-05	0.000176	CcSEcCtD
Montelukast—Urticaria—Topiramate—epilepsy syndrome	4.39e-05	0.000172	CcSEcCtD
Montelukast—Abdominal pain—Topiramate—epilepsy syndrome	4.36e-05	0.000171	CcSEcCtD
Montelukast—Body temperature increased—Topiramate—epilepsy syndrome	4.36e-05	0.000171	CcSEcCtD
Montelukast—Dizziness—Gabapentin—epilepsy syndrome	4.34e-05	0.00017	CcSEcCtD
Montelukast—Nausea—Pregabalin—epilepsy syndrome	4.25e-05	0.000166	CcSEcCtD
Montelukast—Vomiting—Gabapentin—epilepsy syndrome	4.17e-05	0.000163	CcSEcCtD
Montelukast—Rash—Gabapentin—epilepsy syndrome	4.14e-05	0.000162	CcSEcCtD
Montelukast—Dermatitis—Gabapentin—epilepsy syndrome	4.13e-05	0.000162	CcSEcCtD
Montelukast—Headache—Gabapentin—epilepsy syndrome	4.11e-05	0.000161	CcSEcCtD
Montelukast—Hypersensitivity—Topiramate—epilepsy syndrome	4.07e-05	0.000159	CcSEcCtD
Montelukast—Asthenia—Topiramate—epilepsy syndrome	3.96e-05	0.000155	CcSEcCtD
Montelukast—Pruritus—Topiramate—epilepsy syndrome	3.91e-05	0.000153	CcSEcCtD
Montelukast—Nausea—Gabapentin—epilepsy syndrome	3.9e-05	0.000153	CcSEcCtD
Montelukast—Diarrhoea—Topiramate—epilepsy syndrome	3.78e-05	0.000148	CcSEcCtD
Montelukast—Dizziness—Topiramate—epilepsy syndrome	3.65e-05	0.000143	CcSEcCtD
Montelukast—Vomiting—Topiramate—epilepsy syndrome	3.51e-05	0.000137	CcSEcCtD
Montelukast—Rash—Topiramate—epilepsy syndrome	3.48e-05	0.000136	CcSEcCtD
Montelukast—Dermatitis—Topiramate—epilepsy syndrome	3.48e-05	0.000136	CcSEcCtD
Montelukast—Headache—Topiramate—epilepsy syndrome	3.46e-05	0.000135	CcSEcCtD
Montelukast—Nausea—Topiramate—epilepsy syndrome	3.28e-05	0.000128	CcSEcCtD
Montelukast—CYP2C9—Metabolism—EPM2A—epilepsy syndrome	1.81e-05	0.00019	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NHLRC1—epilepsy syndrome	1.81e-05	0.00019	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PNPO—epilepsy syndrome	1.81e-05	0.00019	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.8e-05	0.000189	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.8e-05	0.000189	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CACNA1D—epilepsy syndrome	1.8e-05	0.000189	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.79e-05	0.000188	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NGF—epilepsy syndrome	1.78e-05	0.000187	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TXNRD1—epilepsy syndrome	1.78e-05	0.000187	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCR5—epilepsy syndrome	1.73e-05	0.000182	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AQP1—epilepsy syndrome	1.73e-05	0.000181	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.72e-05	0.000181	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GPX1—epilepsy syndrome	1.7e-05	0.000179	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.7e-05	0.000178	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ATIC—epilepsy syndrome	1.68e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—UPB1—epilepsy syndrome	1.68e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NEU1—epilepsy syndrome	1.68e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TXNRD1—epilepsy syndrome	1.68e-05	0.000177	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—QDPR—epilepsy syndrome	1.68e-05	0.000176	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CA4—epilepsy syndrome	1.68e-05	0.000176	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—POMC—epilepsy syndrome	1.67e-05	0.000176	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.66e-05	0.000174	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AQP1—epilepsy syndrome	1.63e-05	0.000171	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HSD17B4—epilepsy syndrome	1.62e-05	0.00017	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TSC2—epilepsy syndrome	1.61e-05	0.000169	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AGT—epilepsy syndrome	1.61e-05	0.000169	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—COX3—epilepsy syndrome	1.58e-05	0.000166	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—APOE—epilepsy syndrome	1.58e-05	0.000166	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PPP1R3C—epilepsy syndrome	1.56e-05	0.000164	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GBE1—epilepsy syndrome	1.56e-05	0.000164	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—KCNJ11—epilepsy syndrome	1.56e-05	0.000164	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CHRM3—epilepsy syndrome	1.56e-05	0.000164	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KDR—epilepsy syndrome	1.55e-05	0.000162	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.53e-05	0.000161	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CACNA2D2—epilepsy syndrome	1.5e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC6A8—epilepsy syndrome	1.5e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PFKL—epilepsy syndrome	1.5e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLCO1A2—epilepsy syndrome	1.5e-05	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—KCNB1—epilepsy syndrome	1.5e-05	0.000157	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AGT—epilepsy syndrome	1.49e-05	0.000157	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PRKCB—epilepsy syndrome	1.49e-05	0.000156	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6ST—epilepsy syndrome	1.48e-05	0.000156	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	1.48e-05	0.000155	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	1.48e-05	0.000155	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ASAH1—epilepsy syndrome	1.47e-05	0.000154	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.46e-05	0.000154	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—APOE—epilepsy syndrome	1.46e-05	0.000154	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.45e-05	0.000153	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.45e-05	0.000153	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—STXBP1—epilepsy syndrome	1.43e-05	0.00015	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.42e-05	0.00015	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALAD—epilepsy syndrome	1.39e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NT5E—epilepsy syndrome	1.39e-05	0.000146	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—UPB1—epilepsy syndrome	1.37e-05	0.000144	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NEU1—epilepsy syndrome	1.37e-05	0.000144	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ATIC—epilepsy syndrome	1.37e-05	0.000144	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—POMC—epilepsy syndrome	1.36e-05	0.000142	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALDH7A1—epilepsy syndrome	1.33e-05	0.00014	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CACNA1A—epilepsy syndrome	1.33e-05	0.00014	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCL2—epilepsy syndrome	1.33e-05	0.000139	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HSD17B4—epilepsy syndrome	1.32e-05	0.000138	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ST3GAL3—epilepsy syndrome	1.3e-05	0.000137	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADSL—epilepsy syndrome	1.27e-05	0.000134	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GBE1—epilepsy syndrome	1.27e-05	0.000134	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PPP1R3C—epilepsy syndrome	1.27e-05	0.000134	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCG2—epilepsy syndrome	1.27e-05	0.000134	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—POMC—epilepsy syndrome	1.26e-05	0.000132	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GLUL—epilepsy syndrome	1.25e-05	0.000131	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.24e-05	0.000131	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2C19—epilepsy syndrome	1.24e-05	0.00013	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP11A1—epilepsy syndrome	1.23e-05	0.000129	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CACNA1D—epilepsy syndrome	1.23e-05	0.000129	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.22e-05	0.000128	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	1.2e-05	0.000126	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGF2—epilepsy syndrome	1.2e-05	0.000126	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ASAH1—epilepsy syndrome	1.2e-05	0.000126	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.19e-05	0.000125	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.19e-05	0.000125	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.19e-05	0.000125	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.19e-05	0.000125	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	1.17e-05	0.000123	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	1.16e-05	0.000122	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—STXBP1—epilepsy syndrome	1.16e-05	0.000122	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TXNRD1—epilepsy syndrome	1.15e-05	0.000121	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—epilepsy syndrome	1.15e-05	0.00012	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALAD—epilepsy syndrome	1.13e-05	0.000119	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NT5E—epilepsy syndrome	1.13e-05	0.000119	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.11e-05	0.000117	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AQP1—epilepsy syndrome	1.11e-05	0.000117	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RELA—epilepsy syndrome	1.11e-05	0.000117	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP2D6—epilepsy syndrome	1.11e-05	0.000117	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.11e-05	0.000116	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.11e-05	0.000116	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.1e-05	0.000116	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MTOR—epilepsy syndrome	1.09e-05	0.000115	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALDH7A1—epilepsy syndrome	1.08e-05	0.000114	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CACNA1A—epilepsy syndrome	1.08e-05	0.000114	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.07e-05	0.000112	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ST3GAL3—epilepsy syndrome	1.06e-05	0.000111	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ADRA2A—epilepsy syndrome	1.06e-05	0.000111	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—BCHE—epilepsy syndrome	1.05e-05	0.000111	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	1.05e-05	0.00011	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.04e-05	0.000109	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADSL—epilepsy syndrome	1.04e-05	0.000109	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GLUL—epilepsy syndrome	1.02e-05	0.000107	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.01e-05	0.000106	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CHRM3—epilepsy syndrome	1.01e-05	0.000106	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—KCNJ11—epilepsy syndrome	1.01e-05	0.000106	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—SLC2A1—epilepsy syndrome	1.01e-05	0.000106	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—epilepsy syndrome	1e-05	0.000105	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTGS2—epilepsy syndrome	1e-05	0.000105	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	1e-05	0.000105	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CACNA1D—epilepsy syndrome	9.99e-06	0.000105	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—BCHE—epilepsy syndrome	9.97e-06	0.000105	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PLCB1—epilepsy syndrome	9.94e-06	0.000104	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TH—epilepsy syndrome	9.91e-06	0.000104	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	9.87e-06	0.000104	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	9.87e-06	0.000104	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	9.87e-06	0.000104	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PFKL—epilepsy syndrome	9.87e-06	0.000104	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	9.87e-06	0.000104	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.75e-06	0.000102	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JUN—epilepsy syndrome	9.74e-06	0.000102	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	9.51e-06	9.99e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MMP9—epilepsy syndrome	9.48e-06	9.96e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	9.4e-06	9.88e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.38e-06	9.86e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TH—epilepsy syndrome	9.37e-06	9.84e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	9.34e-06	9.81e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—epilepsy syndrome	9.2e-06	9.66e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.2e-06	9.66e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AQP1—epilepsy syndrome	9.07e-06	9.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.03e-06	9.48e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.03e-06	9.48e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.03e-06	9.48e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SRC—epilepsy syndrome	8.74e-06	9.18e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.71e-06	9.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	8.69e-06	9.13e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—epilepsy syndrome	8.51e-06	8.94e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GBE1—epilepsy syndrome	8.39e-06	8.82e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	8.39e-06	8.82e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HMOX1—epilepsy syndrome	8.27e-06	8.69e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCG2—epilepsy syndrome	8.21e-06	8.63e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	8.2e-06	8.62e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	8.2e-06	8.62e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CAT—epilepsy syndrome	8.16e-06	8.57e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2C19—epilepsy syndrome	8.01e-06	8.41e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP11A1—epilepsy syndrome	7.96e-06	8.36e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—epilepsy syndrome	7.94e-06	8.34e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	7.9e-06	8.3e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	7.89e-06	8.29e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	7.82e-06	8.21e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CAT—epilepsy syndrome	7.72e-06	8.1e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	7.68e-06	8.06e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.64e-06	8.02e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	7.51e-06	7.88e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.48e-06	7.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NT5E—epilepsy syndrome	7.48e-06	7.86e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALAD—epilepsy syndrome	7.48e-06	7.86e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPX1—epilepsy syndrome	7.38e-06	7.75e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	7.2e-06	7.56e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP2D6—epilepsy syndrome	7.18e-06	7.54e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.14e-06	7.5e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.14e-06	7.5e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	6.98e-06	7.34e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPX1—epilepsy syndrome	6.98e-06	7.33e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADSL—epilepsy syndrome	6.84e-06	7.19e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADRA2A—epilepsy syndrome	6.84e-06	7.18e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—BCHE—epilepsy syndrome	6.81e-06	7.15e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GLUL—epilepsy syndrome	6.71e-06	7.05e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	6.69e-06	7.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	6.59e-06	6.92e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	6.52e-06	6.84e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC2A1—epilepsy syndrome	6.49e-06	6.82e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	6.48e-06	6.8e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AGT—epilepsy syndrome	6.47e-06	6.8e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.43e-06	6.75e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PLCB1—epilepsy syndrome	6.42e-06	6.75e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TH—epilepsy syndrome	6.4e-06	6.72e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—APOE—epilepsy syndrome	6.34e-06	6.66e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.3e-06	6.62e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.16e-06	6.47e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AGT—epilepsy syndrome	6.12e-06	6.43e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—APOE—epilepsy syndrome	5.99e-06	6.3e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AQP1—epilepsy syndrome	5.98e-06	6.28e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.86e-06	6.16e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	5.84e-06	6.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	5.56e-06	5.84e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—BCHE—epilepsy syndrome	5.54e-06	5.82e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—POMC—epilepsy syndrome	5.45e-06	5.72e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—epilepsy syndrome	5.43e-06	5.71e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.41e-06	5.68e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.41e-06	5.68e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HMOX1—epilepsy syndrome	5.34e-06	5.61e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	5.29e-06	5.55e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CAT—epilepsy syndrome	5.27e-06	5.54e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	5.23e-06	5.49e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TH—epilepsy syndrome	5.21e-06	5.47e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—POMC—epilepsy syndrome	5.15e-06	5.41e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	5.13e-06	5.39e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—epilepsy syndrome	5.13e-06	5.39e-05	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—epilepsy syndrome	5.03e-06	5.29e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—epilepsy syndrome	4.97e-06	5.22e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPX1—epilepsy syndrome	4.77e-06	5.01e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—epilepsy syndrome	4.7e-06	4.93e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.41e-06	4.63e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	4.35e-06	4.57e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTGS2—epilepsy syndrome	4.34e-06	4.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.3e-06	4.51e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CAT—epilepsy syndrome	4.29e-06	4.51e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.27e-06	4.49e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AGT—epilepsy syndrome	4.18e-06	4.39e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	4.17e-06	4.38e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	4.11e-06	4.31e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—APOE—epilepsy syndrome	4.09e-06	4.3e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPX1—epilepsy syndrome	3.88e-06	4.07e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	3.85e-06	4.05e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.67e-06	3.85e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.65e-06	3.84e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—POMC—epilepsy syndrome	3.52e-06	3.7e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.49e-06	3.66e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.45e-06	3.62e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TH—epilepsy syndrome	3.44e-06	3.61e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AGT—epilepsy syndrome	3.4e-06	3.57e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—APOE—epilepsy syndrome	3.33e-06	3.5e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—epilepsy syndrome	3.21e-06	3.37e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	2.87e-06	3.01e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—POMC—epilepsy syndrome	2.86e-06	3.01e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CAT—epilepsy syndrome	2.83e-06	2.97e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTGS2—epilepsy syndrome	2.81e-06	2.95e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.75e-06	2.89e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—epilepsy syndrome	2.61e-06	2.74e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.56e-06	2.69e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	2.28e-06	2.4e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.24e-06	2.36e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.2e-06	2.31e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—epilepsy syndrome	2.18e-06	2.29e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—epilepsy syndrome	2.06e-06	2.17e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.89e-06	1.98e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.72e-06	1.81e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.51e-06	1.58e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—epilepsy syndrome	1.41e-06	1.48e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.15e-06	1.21e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—epilepsy syndrome	7.57e-07	7.95e-06	CbGpPWpGaD
